OncoDaily Grand Rounds: AI in Oncology Edition was convened during ASCO 2026 in Chicago, with ZS serving as the exclusive partner. Held on May 30, 2026, from 5:00 to 8:00 PM at the Hyatt Regency McCormick Place, the evening brought together a diverse group of leaders working across oncology, life sciences, technology, diagnostics, data science, and patient advocacy.

The program created a space for scientific exchange and meaningful professional networking around one of the most important questions facing modern cancer care: how can artificial intelligence be responsibly integrated into research, clinical decision-making, care delivery, and the future of oncology practice?

More than 250 participants attended, including leaders from organizations such as AstraZeneca, Johnson & Johnson, Tempus, PathAI, ConcertAI, AlphaMab, Biocartis, Triomics, Cureety, and the American Oncology Network, alongside experts in precision medicine, digital pathology, real-world data, clinical genomics, health policy, and patient advocacy. Through this multidisciplinary dialogue, the Grand Rounds explored not only the potential of AI to accelerate innovation, but also the need to ensure that its use remains evidence-based, equitable, transparent, and centered on patients.